Mushroom extract may fight smoke damage, early trial hints

NCT ID NCT07316400

First seen Jan 11, 2026 · Last updated Jun 23, 2026 · Updated 31 times

Summary

This study tested whether a daily supplement made from a mushroom extract (PsP) could reduce markers of oxidative stress and inflammation in 200 adults who smoke or are exposed to smoke. Participants took either PsP or a placebo for 8 weeks, and researchers measured changes in blood levels of certain chemicals linked to cell damage and inflammation. The goal is to see if this natural supplement might help protect the body from some harmful effects of cigarette smoke.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Brawijaya

    Malang, East Java, 65145, Indonesia

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Polysaccharide peptide (PsP) from Ganoderma lucidum mushroom extract

What this could lead to

If it works, this could point toward a natural supplement to help reduce some harmful effects of smoking on the body.

What could go wrong

This is a small, early-stage trial measuring only blood markers, not health outcomes. The supplement may show no benefit or could interact with other medications.

Conditions

The condition(s) this trial relates to.

Cigarette Smoking Inflammation inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.